These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 11973649

  • 1. Differential regulation of the response to DNA damage in Ewing's sarcoma cells by ETS1 and EWS/FLI-1.
    Soldatenkov VA, Trofimova IN, Rouzaut A, McDermott F, Dritschilo A, Notario V.
    Oncogene; 2002 Apr 25; 21(18):2890-5. PubMed ID: 11973649
    [Abstract] [Full Text] [Related]

  • 2. Regulation of the human poly(ADP-ribose) polymerase promoter by the ETS transcription factor.
    Soldatenkov VA, Albor A, Patel BK, Dreszer R, Dritschilo A, Notario V.
    Oncogene; 1999 Jul 08; 18(27):3954-62. PubMed ID: 10435618
    [Abstract] [Full Text] [Related]

  • 3. Induction of tenascin-C by tumor-specific EWS-ETS fusion genes.
    Watanabe G, Nishimori H, Irifune H, Sasaki Y, Ishida S, Zembutsu H, Tanaka T, Kawaguchi S, Wada T, Hata J, Kusakabe M, Yoshida K, Nakamura Y, Tokino T.
    Genes Chromosomes Cancer; 2003 Mar 08; 36(3):224-32. PubMed ID: 12557222
    [Abstract] [Full Text] [Related]

  • 4. GSTM4 is a microsatellite-containing EWS/FLI target involved in Ewing's sarcoma oncogenesis and therapeutic resistance.
    Luo W, Gangwal K, Sankar S, Boucher KM, Thomas D, Lessnick SL.
    Oncogene; 2009 Nov 19; 28(46):4126-32. PubMed ID: 19718047
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of apoptosis by normal and aberrant Fli-1 and erg proteins involved in human solid tumors and leukemias.
    Yi H, Fujimura Y, Ouchida M, Prasad DD, Rao VN, Reddy ES.
    Oncogene; 1997 Mar 20; 14(11):1259-68. PubMed ID: 9178886
    [Abstract] [Full Text] [Related]

  • 6. Regulatory role of mevalonate and N-linked glycosylation in proliferation and expression of the EWS/FLI-1 fusion protein in Ewing's sarcoma cells.
    Wang M, Xie Y, Girnita L, Nilsson G, Dricu A, Wejde J, Larsson O.
    Exp Cell Res; 1999 Jan 10; 246(1):38-46. PubMed ID: 9882513
    [Abstract] [Full Text] [Related]

  • 7. Targeting of EWS/FLI-1 by RNA interference attenuates the tumor phenotype of Ewing's sarcoma cells in vitro.
    Chansky HA, Barahmand-Pour F, Mei Q, Kahn-Farooqi W, Zielinska-Kwiatkowska A, Blackburn M, Chansky K, Conrad EU, Bruckner JD, Greenlee TK, Yang L.
    J Orthop Res; 2004 Jul 10; 22(4):910-7. PubMed ID: 15183454
    [Abstract] [Full Text] [Related]

  • 8. A link between basic fibroblast growth factor (bFGF) and EWS/FLI-1 in Ewing's sarcoma cells.
    Girnita L, Girnita A, Wang M, Meis-Kindblom JM, Kindblom LG, Larsson O.
    Oncogene; 2000 Aug 31; 19(37):4298-301. PubMed ID: 10980604
    [Abstract] [Full Text] [Related]

  • 9. The sensitivity of the Ewing's sarcoma family of tumours to fenretinide-induced cell death is increased by EWS-Fli1-dependent modulation of p38(MAPK) activity.
    Myatt SS, Burchill SA.
    Oncogene; 2008 Feb 07; 27(7):985-96. PubMed ID: 17700534
    [Abstract] [Full Text] [Related]

  • 10. EWS/ETS fusions activate telomerase in Ewing's tumors.
    Takahashi A, Higashino F, Aoyagi M, Yoshida K, Itoh M, Kyo S, Ohno T, Taira T, Ariga H, Nakajima K, Hatta M, Kobayashi M, Sano H, Kohgo T, Shindoh M.
    Cancer Res; 2003 Dec 01; 63(23):8338-44. PubMed ID: 14678994
    [Abstract] [Full Text] [Related]

  • 11. Preferential down-regulation of phospholipase C-beta in Ewing's sarcoma cells transfected with antisense EWS-Fli-1.
    Dohjima T, Ohno T, Banno Y, Nozawa Y, Wen-yi Y, Shimizu K.
    Br J Cancer; 2000 Jan 01; 82(1):16-9. PubMed ID: 10638960
    [Abstract] [Full Text] [Related]

  • 12. EWS/FLI-1 antagonists induce growth inhibition of Ewing tumor cells in vitro.
    Kovar H, Aryee DN, Jug G, Henöckl C, Schemper M, Delattre O, Thomas G, Gadner H.
    Cell Growth Differ; 1996 Apr 01; 7(4):429-37. PubMed ID: 9052984
    [Abstract] [Full Text] [Related]

  • 13. Analysis of the expression of cell cycle regulators in Ewing cell lines: EWS-FLI-1 modulates p57KIP2and c-Myc expression.
    Dauphinot L, De Oliveira C, Melot T, Sevenet N, Thomas V, Weissman BE, Delattre O.
    Oncogene; 2001 May 31; 20(25):3258-65. PubMed ID: 11423975
    [Abstract] [Full Text] [Related]

  • 14. Combined transcriptional and translational targeting of EWS/FLI-1 in Ewing's sarcoma.
    Mateo-Lozano S, Gokhale PC, Soldatenkov VA, Dritschilo A, Tirado OM, Notario V.
    Clin Cancer Res; 2006 Nov 15; 12(22):6781-90. PubMed ID: 17121899
    [Abstract] [Full Text] [Related]

  • 15. Upregulation of Id2, an oncogenic helix-loop-helix protein, is mediated by the chimeric EWS/ets protein in Ewing sarcoma.
    Fukuma M, Okita H, Hata J, Umezawa A.
    Oncogene; 2003 Jan 09; 22(1):1-9. PubMed ID: 12527902
    [Abstract] [Full Text] [Related]

  • 16. A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG.
    Sorensen PH, Lessnick SL, Lopez-Terrada D, Liu XF, Triche TJ, Denny CT.
    Nat Genet; 1994 Feb 09; 6(2):146-51. PubMed ID: 8162068
    [Abstract] [Full Text] [Related]

  • 17. Repression of the gene encoding the TGF-beta type II receptor is a major target of the EWS-FLI1 oncoprotein.
    Hahm KB, Cho K, Lee C, Im YH, Chang J, Choi SG, Sorensen PH, Thiele CJ, Kim SJ.
    Nat Genet; 1999 Oct 09; 23(2):222-7. PubMed ID: 10508522
    [Abstract] [Full Text] [Related]

  • 18. Homotypic and heterotypic interactions of EWS, FLI1 and their oncogenic fusion protein.
    Spahn L, Siligan C, Bachmaier R, Schmid JA, Aryee DN, Kovar H.
    Oncogene; 2003 Oct 09; 22(44):6819-29. PubMed ID: 14534527
    [Abstract] [Full Text] [Related]

  • 19. FLI1 and EWS-FLI1 function as ternary complex factors and ELK1 and SAP1a function as ternary and quaternary complex factors on the Egr1 promoter serum response elements.
    Watson DK, Robinson L, Hodge DR, Kola I, Papas TS, Seth A.
    Oncogene; 1997 Jan 16; 14(2):213-21. PubMed ID: 9010223
    [Abstract] [Full Text] [Related]

  • 20. Ewing's sarcoma fusion protein, EWS/Fli-1 and Fli-1 protein induce PLD2 but not PLD1 gene expression by binding to an ETS domain of 5' promoter.
    Kikuchi R, Murakami M, Sobue S, Iwasaki T, Hagiwara K, Takagi A, Kojima T, Asano H, Suzuki M, Banno Y, Nozawa Y, Murate T.
    Oncogene; 2007 Mar 15; 26(12):1802-10. PubMed ID: 16964281
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.